Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11946876 | 0.92 | CA12 (0.39) | CA12CA1CA2CA9USP2 | |
| SCHEMBL770546 | 0.92 | CA12 (0.39) | CA12CA1CA2CA9USP2 | |
| SCHEMBL16659367 | 0.85 | USP2 (0.37) | CA12CA1CA2CA9USP2 | |
| SCHEMBL16659368 | 0.75 | USP2 (0.31) | USP2 | |
| SCHEMBL13899788 | 0.75 | TSHR (0.43) | USP2 | |
| SCHEMBL23085322 | 0.75 | ALOX15 (0.38) | USP2KDM4E | |
| SCHEMBL616077 | 0.74 | — | — | |
| SCHEMBL2500023 | 0.74 | ADH1A (0.33) | — | |
| Formic Acid SCHEMBL2960819 | 0.73 | CA12 (0.47) | CA12CA1CA2CA9USP2 | |
| SCHEMBL9574397 | 0.72 | ALOX15 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2646489-B1 | BLOWING CATALYST | HUNTSMAN CORP HUNGARY ZRT (HU) | 2018-07-04 | — | — | EP | disclosed |
| US-9382397-B2 | Blowing catalyst | Huntsman Corporation Hungary ZRt (HU) | 2016-07-05 | — | — | US | disclosed |
| EP-2438038-B1 | PROCESS FOR THE PREPARATION OF SECONDARY OR TERTIARY AMINES | HUNTSMAN CORP HUNGARY ZRT (HU) | 2016-04-20 | — | — | EP | disclosed |
| US-8822729-B2 | Method for providing a secondary or tertiary amine | HUNTSMAN INTERNATIONAL LLC (US) | 2014-09-02 | — | — | US | disclosed |
| US-20140155655-A1 | Method for providing a secondary or tertiary amine | Huntsman Corporation Hungary ZRt (HU) | 2014-06-05 | — | — | US | disclosed |
| US-8664445-B2 | Method for providing a secondary or tertiary amine | HUNTSMAN INTERNATIONAL LLC (US) | 2014-03-04 | — | — | US | disclosed |
| US-20130261199-A1 | Blowing Catalyst | Huntsman Corporation Hungary ZRt (HU) | 2013-10-03 | — | — | US | disclosed |
| WO-2012072441-A1 | BLOWING CATALYST | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2012-06-07 | — | — | WO | disclosed |
| US-20120071622-A1 | Method for Providing a Secondary or Tertiary Amine | Huntsman Corporation Hungary ZRt (HU) | 2012-03-22 | — | — | US | disclosed |
| WO-2010139521-A1 | A METHOD FOR PROVIDING A SECONDARY OR TERTIARY AMINE | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2010-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071622-A1 | Method for Providing a Secondary or Tertiary Amine | HRH3, HRH4, NPR3 | CA12 2348/4885CA1 2782/4885CA2 1997/4885 |
| US-20140155655-A1 | Method for providing a secondary or tertiary amine | HRH3, HRH4, GLRA3 | CA12 2557/4885CA1 2923/4885CA2 2129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.